| |
|
|
Il Sung Pharm. (003120) |
|
|
STOCK |
|
|
| Address |
44-7,WONHYORO 1-GA, YONGSAN-GU,SEOUL |
| Home Page |
www.ilsung-ph.co.kr
|
| Established |
1961. 2.15 |
Tel |
02-3271-8800 |
| Listed |
1985. 1.14 |
IR |
|
| Common shares O/S |
2,660,000 |
President |
Yun,Seok Geun |
| Preferred shares O/S |
|
No.of Employees |
315(2007. 6) |
| The sales growth continues due to the sales of tablets including Ogumentin and other products of injection and syrups. It has a good profit structure that the cost ratio is low and the share held guarantees the high dividend income. It maintains a stable financial structure based on the affluent liquidity with no borrowing management status. |
| The sales will go up as our society entering senile status and chronic diseases are spreading accordingly. It will maintain a sound profit structure based on the steady operating profit earning and the current net profit to be expected. It will launch Tamoxipen for anticancer medicine, Ilsung Megestrol liquid for appetizing cancer patients, Nuridal for the motor disturbance medicine. |
|
  |
(date: 2007.06, unit : %) |
| Name |
CISCO |
Yoon Hyeongjin |
Yoon Yeonggeun |
| Portion |
18.5 |
9.2 |
6.4 |
|
 |
(unit : %) |
| Sales |
Augmentin |
29.3 |
Cost |
Raw Materials |
|
| Ilsungiofamiro(300/100ml) |
24.8 |
Labors |
|
| Others |
33.1 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
85. 1 |
85.10 |
86.10 |
87. 6 |
98. 7 |
| Type |
LI |
RI |
RI |
RI |
RI |
| Amount |
43.00 |
20.00 |
20.00 |
20.00 |
30.00 |
|
|
|
|
